Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS)

Am J Hematol. 2022 Aug;97(8):E292-E295. doi: 10.1002/ajh.26598. Epub 2022 May 31.
No abstract available

Publication types

  • Clinical Trial, Phase IV
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoates / therapeutic use
  • Child
  • Deferasirox
  • Hemosiderosis* / etiology
  • Hemosiderosis* / therapy
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Iron Overload*
  • Tablets

Substances

  • Benzoates
  • Iron Chelating Agents
  • Tablets
  • Deferasirox